Azurity Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.azurity.com
FDA Approves Nilotinib Tablets (Danziten) Without Mealtime Restrictions for CML
The FDA has approved nilotinib tablets (Danziten) for Philadelphia chromosome-positive chronic myeloid leukemia (CML) patients, offering a new treatment option.
© Copyright 2025. All Rights Reserved by MedPath